Characterisation of the effects of caffeine on sleep in the rat: A potential model of sleep disruption

Journal of Psychopharmacology

Volumn 23, Issue 5, 2009, Pages 475-486

  Paterson, L M ^a   Wilson, S J ^a   Nutt, D J ^a   Hutson, P H ^b,c   Ivarsson, M ^b,d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

5 HT; Caffeine; EEG; Insomnia; Rat; Sleep; Telemetry; Trazodone; Zolpidem

Indexed keywords

CAFFEINE; TRAZODONE; ZOLPIDEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE MEASUREMENT; CONTROLLED STUDY; DELTA RHYTHM; DOSE RESPONSE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EXPERIMENTAL MODEL; INSOMNIA; LOCOMOTION; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SCORING SYSTEM; SLEEP TIME; SLEEP WAKING CYCLE;

ANIMALS; BODY TEMPERATURE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; HYPNOTICS AND SEDATIVES; MALE; MOTOR ACTIVITY; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TELEMETRY; TRAZODONE;

EID: 67449116879     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109104846     Document Type: Article

References (58)

1. Adam K., Tomeny M., Oswald I., (1986) Physiological and psychological differences between good and poor sleepers. J Psychiatr Res 20: 301-316. (Pubitemid 17200250)
2. Anderson NJ., Reynolds DS., Stendsbol TB., (2006) Effects of the 5HT-2A antagonist MDL100907 on rat sleep parameters. J Sleep Res 15: P211.
3. Antoniou K., Papadopoulou-Daifoti Z., Hyphantis T., Papathanasiou G., Bekris E., Marselos M., (2005) A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors. Psychopharmacology 183: 154-162. (Pubitemid 41609267)
4. Bonnet MH., Arand DL., (1992) Caffeine use as a model of acute and chronic insomnia. Sleep 15: 526-536.
5. Bonnet MH., Arand DL., (2001) Impact of activity and arousal upon spectral EEG parameters. Physiol Behav 74: 291-298. (Pubitemid 33070401)
6. Borbely AA., Baumann F., Brandeis D., Strauch I., Lehmann D., (1981) Sleep deprivation: effect on sleep stages and EEG power density in man. Electroencephalogr Clin Neurophysiol 51: 483-495.
7. Borbely AA., Trachsel L., Tobler I., (1988) Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol 156: 275-278. (Pubitemid 18260489)
8. Boutrel B., Koob GF., (2004) What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27: 1181-1194. (Pubitemid 39331091)
9. Brocco M., Dekeyne A., Veiga S., Girardon S., Millan MJ., (2002) Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 71: 667-680. (Pubitemid 34219217)
10. Brunner DP., Dijk DJ., Munch M., Borbely AA., (1991) Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology 104: 1-5.
11. Caccia S., Ballabio M., Fanelli R., Guiso G., Zanini MG., (1981) Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine, by gas-liquid chromatography. J Chromatogr 210: 311-318. (Pubitemid 11001993)
12. Carter AJ., O'Connor WT., Carter MJ., Ungerstedt U., (1995) Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors. J Pharmacol Exp Ther 273: 637-642.
13. Cysneiros RM., Farkas D., Harmatz JS., von Moltke LL., Greenblatt DJ., (2007) Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther 82: 54-62. (Pubitemid 46944198)
14. Deboer T., (1998) Brain temperature dependent changes in the electroencephalogram power spectrum of humans and animals. J Sleep Res 7: 254-262. (Pubitemid 28515557)
15. Depoortere H., Zivkovic B., Lloyd KG., Sanger DJ., Perrault G., Langer SZ., (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237: 649-658. (Pubitemid 16092830)
16. Dijk DJ., Brunner DP., Borbely AA., (1990) Time course of EEG power density during long sleep in humans. Am J Physiol 258: R650-R661.
17. Drapeau C., Hamel-Hebert I., Robillard R., Selmaoui B., Filipini D., Carrier J., (2006) Challenging sleep in aging: the effects of 200?mg of caffeine during the evening in young and middle-aged moderate caffeine consumers. J Sleep Res 15: 133-141. (Pubitemid 43756211)
18. El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois JM., (2003) Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 45: 977-985. (Pubitemid 37297923)
19. Erman MK., Erwin CW., Gengo FM., Jamieson AO., Lemmi H., Mahowald MW., (2001) Comparative efficacy of zolpidem and temazepam in transient insomnia. Hum Psychopharmacol 16: 169-176. (Pubitemid 32236982)
20. Fish LR., Gilligan MT., Humphries AC., Ivarsson M., Ladduwahetty T., Merchant KJ., (2005) 4-Fluorosulfonylpiperidines: selective 5-HT2A ligands for the treatment of insomnia. Bioorg Med Chem Lett 15: 3665-3669. (Pubitemid 41038956)
21. Fredholm BB., Battig K., Holmen J., Nehlig A., Zvartau EE., (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133. (Pubitemid 29113867)
22. Garrigou-Gadenne D., Burke JT., Durand A., Depoortere H., Thenot JP., Morselli PL., (1989) Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 248: 1283 - 1288. (Pubitemid 19100785)
23. Gottesmann C., Gandolfo G., Arnaud C., Gauthier P., (1998) The intermediate stage and paradoxical sleep in the rat: influence of three generations of hypnotics. Eur J Neurosci 10: 409-414. (Pubitemid 28325464)
24. Haffmans PM., Vos MS., (1999) The effects of trazodone on sleep disturbances induced by brofaromine. Eur Psychiatry 14: 167-171. (Pubitemid 36187799)
25. Hicks JA., Argyropoulos SV., Rich AS., Nash JR., Bell CJ., Edwards C., (2002) Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry 180: 528-535. (Pubitemid 34596804)
26. Hindmarch I., Rigney U., Stanley N., Quinlan P., Rycroft J., Lane J., (2000) A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology 149: 203-216. (Pubitemid 30262333)
27. Ivarsson M., Paterson LM., Hutson PH., (2005) Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats. Eur J Pharmacol 522: 63-71. (Pubitemid 41456651)
28. Kantor S., Jakus R., Bodizs R., Halasz P., Bagdy G., (2002) Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift. Brain Res 943: 105-111. (Pubitemid 34671178)
29. Landolt HP., (2008) Sleep homeostasis: a role for adenosine in humans ? Biochem Pharmacol 75: 2070-2079.
30. Landolt HP., Dijk DJ., Gaus SE., Borbely AA., (1995) Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology 12: 229-238.
31. Landolt HP., Meier V., Burgess HJ., Finelli LA., Cattelin F., Achermann P., (1999) Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra. Neuropsychopharmacology 21: 455-466. (Pubitemid 29333084)
32. Landolt HP., Retey JV., Tonz K., Gottselig JM., Khatami R., Buckelmuller I., (2004) Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Neuropsychopharmacology 29: 1933-1939. (Pubitemid 39336805)
33. Lelkes Z., Obal F., Alfoldi P., Erdos A., Rubicsek G., Benedek G., (1994) Effects of acute and chronic treatment with trazodone, an antidepressant, on the sleep-wake activity in rats. Pharmacol Res 30: 105-115. (Pubitemid 24341321)
34. Lu J., Greco M.A., (2006) Sleep circuitry and the hypnotic mechanism of GABAA drugs. J Clin Sleep Med 2: S19-S26.
35. Mailliet F., Galloux P., Poisson D., (2001) Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats. Psychopharmacology 156: 417-426. (Pubitemid 32695851)
36. Marek GJ., McDougle CJ., Price LH., Seiden LS., (1992) A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology (Berl) 109: 2-11.
37. Mendelson WB., (2005) A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 66: 469-476. (Pubitemid 40593575)
38. Montgomery I., Oswald I., Morgan K., Adam K., (1983) Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 16: 139-144.
39. Morairty SR., Hedley L., Flores J., Martin R., Kilduff TS., (2008) Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats. Sleep 31: 34-44.
40. Owens MJ., Morgan WN., Plott SJ., Nemeroff CB., (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283: 1305-1322. (Pubitemid 28016506)
41. Paterson LM., Nutt DJ., Ivarsson M., Hutson PH., Wilson SJ., (2009) Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. J Psychopharmacol 23: 487-494.
42. Paterson LM., Wilson SJ., Nutt DJ., Hutson PH., Ivarsson M., (2007) A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. Psychopharmacology 191: 943-950. (Pubitemid 46399141)
43. Popa D., Lena C., Fabre V., Prenat C., Gingrich J., Escourrou P., (2005) Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J Neurosci 25: 11231-11238. (Pubitemid 43083697)
44. Porkka-Heiskanen T., Strecker RE., Thakkar M., Bjorkum AA., Greene RW., McCarley RW., (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276: 1265-1268.
45. Retey JV., Adam M., Khatami R., Luhmann UF., Jung HH., Berger W., (2007) A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 81: 692-698. (Pubitemid 46625104)
46. Saletu-Zyhlarz G., Anderer P., Brandstatter N., Dantendorfer K., Gruber G., Mandl M., (2000) Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiology 41: 139-148. (Pubitemid 30172994)
47. Saletu-Zyhlarz GM., Abu-Bakr MH., Anderer P., Gruber G., Mandl M., Strobl R., (2002) Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 26: 249-260. (Pubitemid 34038051)
48. Schlosberg AJ., (1983) Temperature responses in rats after acute and chronic administrations of caffeine. Pharmacol Biochem Behav 18: 935-942.
49. Schwierin B., Borbely AA., Tobler I., (1996) Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 300: 163-171. (Pubitemid 26144794)
50. Sharpley AL., Solomon RA., Fernando AI., da Roza Davis JM., Cowen PJ., (1990) Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 101: 568-569. (Pubitemid 20220053)
51. Shinomiya K., Omichi J., Ohnishi R., Ito H., Yoshida T., Kamei C., (2004) Effects of chlorogenic acid and its metabolites on the sleep-wakefulness cycle in rats. Eur J Pharmacol 504: 185-189. (Pubitemid 39488214)
52. Strecker RE., Morairty S., Thakkar MM., Porkka-Heiskanen T., Basheer R., Dauphin LJ., (2000) Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav Brain Res 115: 183 - 204. (Pubitemid 30734833)
53. Suzuki H., Yamadera H., Nakamura S., Endo S., (2002) Effects of trazodone and imipramine on the biological rhythm: an analysis of sleep EEG and body core temperature. J Nippon Med Sch 69: 333-341. (Pubitemid 34947925)
54. Thakkar MM., Engemann SC., Walsh KM., Sahota PK., (2008) Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 153: 875-880.
55. Van Bemmel AL., Beersma DG., Van den Hoofdakker RH., (1995) Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone. J Affect Disord 35: 11-19.
56. Varkevisser M., Van Dongen HP., Kerkhof GA., (2005) Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal ? Sleep 28: 1588-1596. (Pubitemid 41747087)
57. Wang Y., Lau CE., (1998) Caffeine has similar pharmacokinetics and behavioral effects via the i.p. and p.o. routes of administration. Pharmacol Biochem Behav 60: 271-278. (Pubitemid 28236640)
58. Yamadera H., Nakamura S., Suzuki H., Endo S., (1998) Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects. Psychiatry Clin Neurosci 52: 439-443. (Pubitemid 28412954)